Business Standard

Granules India dips 10% on 11 observations from Portugal authority

The regulator had detected nonconformities in the good manufacturing practices system

Photo: Shutterstock
Premium

Photo: Shutterstock

Sharath Chowdary Hyderabad
Granules India's share price fell by 10 per cent on Monday reacting to the news reports about a set of critical observations issued by Portuguese drug regulator on its Gagillapur unit near Hyderabad that manufactures pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs).
The scrip closed at 101.20 by the end of the trading session from the previous close of Rs 112.25 while touching a low of 97.80 during the day.
Infarmed (National Authority of Medicines and Health Products), Portugal, had conducted a renewal inspection at the Gagillapur facility on January 6, and the company received the inspection report with eleven observations.
The

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in